5-chloro-4-((5-chloro-6-cyclopropylpyridin-3-yl)oxy)-2-fluoro-N-(methylsulfonyl)benzamide

ID: ALA5286125

Chembl Id: CHEMBL5286125

Max Phase: Preclinical

Molecular Formula: C16H13Cl2FN2O4S

Molecular Weight: 419.26

Associated Items:

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)NC(=O)c1cc(Cl)c(Oc2cnc(C3CC3)c(Cl)c2)cc1F

Standard InChI:  InChI=1S/C16H13Cl2FN2O4S/c1-26(23,24)21-16(22)10-5-11(17)14(6-13(10)19)25-9-4-12(18)15(20-7-9)8-2-3-8/h4-8H,2-3H2,1H3,(H,21,22)

Standard InChI Key:  BJBQASWPUALPOY-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5286125

    ---

Associated Targets(Human)

SCN9A Tclin Sodium channel protein type IX alpha subunit (8393 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCN9A Tclin Sodium channel protein type 9 subunit alpha/beta-1/beta-2 (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCN1A Tclin Sodium channel protein type 1 subunit alpha/beta-1/beta-2 (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCN5A Tclin Sodium channel protein type 5 subunit alpha/beta-1/beta-2 (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Scn9a Sodium channel protein type 9 subunit alpha/beta-1/beta-2 (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 419.26Molecular Weight (Monoisotopic): 417.9957AlogP: 3.89#Rotatable Bonds: 5
Polar Surface Area: 85.36Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.06CX Basic pKa: 3.01CX LogP: 2.56CX LogD: 1.91
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.80Np Likeness Score: -1.19

References

1. Kitano Y, Shinozuka T..  (2022)  Inhibition of NaV1.7: the possibility of ideal analgesics.,  13  (8.0): [PMID:36092147] [10.1039/d2md00081d]
2. Karanjule N, Hayashi N, Suzuki S, Tsuda T, Tokumaru E, Tanaka K, Kimoto H, Domon Y, Takahashi S, Kubota K, Kitano Y, Yokoyama T, Koishi R, Fujiwara C, Inaba S, Asano D, Sakakura T, Takasuna K, Shinozuka T..  (2023)  N-Aryl Indoles as a Novel Class of Potent NaV1.7 Inhibitors.,  14  (6): [PMID:37312847] [10.1021/acsmedchemlett.3c00079]

Source